ArticleAnnals of surgical treatment and research2015
Clinicopathological characteristics and treatment outcomes of 38 cases of primary thyroid lymphoma: a multicenter study.
Article in Annals of surgical treatment and research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed, 61 citations in OpenAlex.
- Primary thyroid diffuse large B-cell lymphoma: a case report and focused review of the literature.Annals of hematology · 2026Review
- Clinicopathological characteristics and surgical value of primary gastrointestinal lymphoma.World journal of gastrointestinal oncology · 2025Article
- Diagnosis and treatment outcomes of primary lymphoma of the thyroid gland.Discover oncology · 2025Article
- Primary Thyroid Lymphoma: A Case Series.Cureus · 2025Article
- Bibliometric analysis and visualization of global research trends in primary thyroid lymphoma via CiteSpace.Gland surgery · 2024Article
- Thyroid papillary carcinoma combined with primary follicular lymphoma: a case report.Diagnostic pathology · 2024Article
- [Clinical characteristics and prognostic analysis of 34 patients with primary thyroid lymphoma].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2024Article
- Primary Thyroid Lymphoma: A Retrospective-Observational Study in a Single Institutional Center.Medicina (Kaunas, Lithuania) · 2024Observational
- Thyroid B-Cell Lymphoma in the Background of Hashimoto's Thyroiditis: A Case Report and Literature Review.Cureus · 2024Article
- Disease-Specific Survival by Treatment Modality in Patients with Stage IE Primary Thyroid Lymphoma: Discussion of Risks and Benefits.Annals of surgical oncology · 2024Article
- [Diffuse large B-cell lymphoma of thyroid invading the superior mediastinum with hashimoto's thyroiditis: a case report and literature review].Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery · 2023Review
- Fast Track Management of Primary Thyroid Lymphoma in the Very Elderly Patient.Current oncology (Toronto, Ont.) · 2023Article
- Primary Thyroid Diffuse Large B-cell Lymphoma in a Child with Hashimoto’s Thyroiditis: A Case ReportJournal of clinical research in pediatric endocrinology · 2023Article
- Diagnosis and treatment of primary thyroid lymphoma from a surgical perspective: a multi-institutional study.Langenbeck's archives of surgery · 2023Article
- Clinicopathological analysis of primary thyroid non-Hodgkin lymphoma: a single-center study.Translational cancer research · 2023Article
- Primary thyroid lymphoma -- report of four cases and literature review.International journal of clinical and experimental pathology · 2023Article
- Coexistence of tuberculosis and extranodal marginal zone lymphoma of the thyroid gland: Case report and literature review.Annals of medicine and surgery (2012) · 2022Article
- Prognostic evaluation models for primary thyroid lymphoma, based on the SEER database and an external validation cohort.Journal of endocrinological investigation · 2022Article
- A Dramatic Response of a Thyroid Lymphoma to R-CHOP Chemotherapy Reversing Mechanical Airway Obstruction and Respiratory Failure.Case reports in endocrinology · 2022Article
- Thyroid lymphoproliferative lesions in Asia.Gland surgery · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposePrimary thyroid lymphoma (PTL) is a rare disease and it has been investigated in a limited number of studies. The present multicenter study evaluated the clinical features and treatment outcomes of PTL.
methodsThe medical records of patients diagnosed with PTL between 2000 and 2013 in three centers were retrospectively reviewed.
resultsThe study included 11 men and 27 women with a median age of 63.3 years (range, 42-83 years). The median follow-up was 56.0 months (range, 3-156 months). Of the 38 patients included, 16 had mucosa-associated lymphoid tissue (MALT) lymphoma, six had mixed MALT and diffuse large B-cell lymphoma (DLBCL), and 16 had DLBCL. Thirty-five patients (92.1%) had early stage (stage I/II) disease. Of the 16 MALT lymphoma patients, 14 were treated by surgery, and radiotherapy (RT) or chemotherapy was combined in five patients. Two patients received RT or chemotherapy alone. Of the six mixed MALT and DLBCL patients, three underwent surgery with chemotherapy and three underwent chemotherapy alone, RT alone, or surgery with RT. All of the 16 DLBCL patients received chemotherapy, and surgery and RT was combined in 4 and 1 patients, respectively. The 5-year survival was 100% for MALT lymphoma (7 of 7) and mixed MALT and DLBCL patients (5 of 5) and 87.5% for DLBCL patients (7 of 8).
conclusionEarly stage PTL has an excellent prognosis when managed by single or combined treatment modalities. Clinicians should consider PTL in patients with underlying Hashimoto's thyroiditis presenting with an enlarging thyroid mass.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.